Enfermedades Neurológicas

Ryvlin, P; Huot, M; Valton, L; Maillard, L; Bartolomei, F; Derambure, P; Hirsch, E; Chassoux, F; Crespel, A; Biraben, A; Navarro, V; Kahane, P; De Toffol, B; Thomas, P; Rosenberg, S; Bernini, A; Charlois, AL; Craciun, L; Chorfa, F; Ducouret, P; Ferreira, A; Leclercq, M; Marty, M; Alvarez, BM; Sampaio, M; Spahr, A; Timestit-Kurland, N; Touya, M; Roy, P; Rheims, S.

Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO2MSE): a prospective, multicentre case-control study

LANCET NEUROLOGY. 2026; 25(1): 50-60 Nº de citas: 8 [doi:10.1016/S1474-4422(25)00379-5]

Montero-Pardo, C; Rocon, E; Dosen, S; Dideriksen, JL; Gutiérrez, A; Pérez-Sánchez, JR; Luque-Buzo, E; Louis, ED; Grandas, F; Oliveira-Barroso, F.

Emerging Noninvasive Approaches for the Suppression of Pathological Tremor

IEEE Reviews in Biomedical Engineering. 2025; 19: 65-85 [doi:10.1109/RBME.2025.3639754]

Rodero-Romero, A; Domínguez-Mozo, M; Monreal, E; García-Domínguez, JM; Villarrubia, N; Fernández-Velasco, JI; Comabella, M; de la Maza, SS; Briceño, HG; Chico-García, JL; García-Martínez, MA; Rodriguez-Jorge, F; Veiga-Gonzalez, JL; Sainz-Amo, R; Ginés, MLM; Montalban, X; Masjuan, J; Costa-Frossard, L; Alvarez-Lafuente, R; Villar, LM.

New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis

Frontiers in Immunology. 2025; 16: Nº de citas: 1 [doi:10.3389/fimmu.2025.1729500]

Muñoz-Vendrell, A; Campoy-Díaz, S; Valín-Villanueva, P; Casas-Limón, J; Fernández-Lázaro, I; González-García, N; Santos-Lasaosa, S; Osorio, YG; Gonzalez-Martinez, A; Campdelacreu, J; Portocarrero-Sánchez, L; Sánchez, LMC; Sánchez, SMG; Pérez-de-la-parte, A; Sánchez-Mateos, NM; López-Bravo, A; Mínguez-Olaondo, A; Sánchez-Soblechero, A; Ros, AL; Hernández, CM; López, AA; Layos-Romero, A; Caronna, E; Torres-Ferrús, M; Alpuente, A; Pozo-Rosich, P; Belvís, R; Garcia-Azorin, D; Díaz-de-Terán, J; Guerrero-Peral, AL; Gago-Veiga, AB; Huerta-Villanueva, M.

Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response

JOURNAL OF HEADACHE AND PAIN. 2025; 27(1): Nº de citas: 1 [doi:10.1186/s10194-025-02239-1]

Sanabria-Gago, C; Lázaro, IF; Heredia, P; Sánchez-Soblechero, A; Ros, AL; Buzo, EL; Osorio, YG; Guerrero-Peral, A; Gonzalez-Martinez, A; Azorín, DG; Latorre, G; Calle, C; Toledo-Alfocea, D; Limon, JC; Valle, SU; Salaices, MG; Avila, GM; Carpio, RT; Pascual, J; González-Quintanilla, V; Madera, J; Polanco, M; Rodríguez-Vico, J; Jaimes, A; García, AG; Cuadrado, ML; Gago-Veiga, AB.

SAFE-CGRP study: multicenter retrospective evaluation of the safety of CGRP pathway-targeting monoclonal antibodies in migraine with relevant comorbidities or conditions excluded from trials

Frontiers in Neurology. 2025; 16: [doi:10.3389/fneur.2025.1703876]

Faggioli, G; Menotti, L; Marchesin, S; Trescato, I; Ahmad, L; Aidos, H; Alungulese, AL; Bellazzi, R; Bergamaschi, R; Birolo, G; Bosoni, P; Cabrera-Umpiérrez, MF; Cavalla, P; Chio, A; Dagliati, A; De Carvalho, M; Fariselli, P; Dominguez, JMG; Martínez, SG; Gromicho, M; Guazzo, A; Jovanovic, A; Kostic, B; Longato, E; Madeira, SC; Manera, U; Blanco, JLM; Tavazzi, E; Tavazzi, E; Iglesias, ET; Urosevic, V; Vettoretti, M; Di Nunzio, GM; Silvello, G; Di Camillo, B; Ferro, N.

The BRAINTEASER Datasets: Clinical, Wearable and Environmental Data for ALS & MS Progression Modeling

Scientific Data. 2025; 12(1): Nº de citas: 1 [doi:10.1038/s41597-025-06095-1]

Mateo-Sierra, O; Romero-Cumbreras, E; García-Llorente, E; Rubín-Alduán, S.

From Crisis Response to Lasting Transformation: Five-Year Insights from the Implementation of Telemedicine in Neurosurgical Care During COVID-19

Healthcare. 2025; 13(22): [doi:10.3390/healthcare13222939]

Sanchez-Larsen, A; Villanueva, AM; Panadés-de Oliveira, L; Mercedes-Alvarez, B; Torres-Lopez, LE; Sopelana-Garay, D; Sanabria-Sanchinel, AA.

Acceptance and perceptions on the 2025 update of the ILAE classification of epileptic seizures: A survey of neurologists and neurology residents

EPILEPSY & BEHAVIOR. 2025; 172: Nº de citas: 3 [doi:10.1016/j.yebeh.2025.110696]

Mateo-Sierra, O; Boto, R; de la Torre, A; Montalvo, A; Pérez-Díaz, D; Rey, C.

Trends in Etiology and Mortality in Severe Polytrauma Patients with Traumatic Brain Injury: A 25-Year Retrospective Analysis

Journal of Clinical Medicine. 2025; 14(19): [doi:10.3390/jcm14196986]

Portela-Sánchez, S; Catalina, I; Muñoz, SL; Ros, AL; Sánchez-Soblechero, A; Vendrel, ES; Sánchez-Mateos, P; Muñoz-Blancoa, JL.

Immune-mediated necrotizing myopathy: experience in a neuromuscular unit

NEUROLOGIA. 2025; 40(8): 729-738 [doi:10.1016/j.nrl.2023.03.005]

Landete, L; Gomez-Ballesteros, R; Meca-Lallana, V; Caminero, AB; Meca-Lallana, JE; Martínez-Yélamos, S; García-Domínguez, JM; Agüera, E; García-Arcelay, E; Medrano, N; Villar, LM; Monreal, E; Maurino, J.

How do neurologists perceive the organization and functioning of multiple sclerosis care units?

Multiple Sclerosis Journal-Experimental Translational and Clinical. 2025; 11(4): [doi:10.1177/20552173251406791]

Márquez-González, M; Gallego-Alberto, L; Losada, A; Merida-Herrera, L; Garcia-Batalloso, I; Bermejo, I; Olazarán, J; Cabrera, I.

Development of a brief scale to measure discrete positive emotions in dementia family caregiving: the positive emotions in caregiving scale (PEC-S)

Journal of Happiness Studies. 2025; 26(7): [doi:10.1007/s10902-025-00946-9]

Prior, MJAA; Singer, PA; Navarro, JO; Garcia, LO; Castello, MM; Beltran-Corbellini, A; Sánchez-Larsen, A; Parejo-Carbonell, B; de Toledo-Heras, M; Campos, AV; Gonzalez-Villar, E; Mercedes-Alvarez, B; Escobar-Montalvo, JM.

Effectiveness and safety of cenobamate in Lennox-Gastaut syndrome: A multicenter real-world study in Spain

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY. 2025; 131: 84-89 Nº de citas: 7 [doi:10.1016/j.seizure.2025.05.011]

Marignier R; Villacieros-Álvarez J; Espejo C; Arrambide G; Fissolo N; Gutiérrez L; Dinoto A; Mulero P; Rubio-Flores L; Nieto P; Alcalá C; Meca-Lallana JE; Martínez-Garcia P; Millán J; Bernard-Valnet R; González I; Orvíz García A; Tellez R; Navarro L; Presas-Rodríguez S; Romero-Pinel L; Martínez-Yélamos S; Cuello JP; Alonso Torres AM; Piñar R; Álvarez Bravo G; Benyahya L; Trouillet-Assant S; Dyon-Tafani V; Froment Tilikete C; Ruet A; Bourre B; Deschamps R; Papeix C; Maillart E; Kerschen P; Ayrignac X; Rovira A; Auger C; Audoin B; Montalban X; Tintore M; Mariotto S; Cobo-Calvo A.

Assessment of neuronal and glial serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease: the MULTIMOGAD study.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2025; 96(9): 884-892 Nº de citas: 9 [doi:10.1136/jnnp-2024-335137]

Fernández-Romero, L; Cabrera-Martin, MN; Delgado-Alonso, C; Suárez-Coalla, P; Grasso, SM; Portolés, A; Pérez-Macías, N; Carreras, MT; Díez-Cirarda, M; Gil-Moreno, MJ; Olazarán, J; Vieira, A; Oliver-Mas, S; Gómez-Pinedo, U; Matías-Guiu, J; Matias-Guiu, JA.

Long-Term Therapy With Transcranial Magnetic Stimulation in Primary Progressive Aphasia A Randomized Clinical Trial

JAMA Network Open. 2025; 8(8): Nº de citas: 3 [doi:10.1001/jamanetworkopen.2025.26129]

Rodero-Romero, A; Fernández-Velasco, JI; Monreal, E; Sainz-Amo, R; Alvarez-Lafuente, R; Comabella, M; Ramió-Torrentà, L; García-Domínguez, JM; Villarrubia, N; de la Maza, SS; Domínguez-Mozo, M; Quiroga-Varela, A; Chico-García, JL; Rodriguez-Jorge, F; Veiga-Gonzalez, JL; Roldán-Santiago, E; Espiño, M; Rodríguez-Martín, E; Alvarez, G; Masjuan, J; Montalban, X; Costa-Frossard, L; Villar, LM.

Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis

Frontiers in Immunology. 2025; 16: Nº de citas: 1 [doi:10.3389/fimmu.2025.1648725]

Losada-Baltar, A; Márquez-González, M; Mausbach, BT; Jiménez-Gonzalo, L; Fernandes-Pires, JA; Olazarán, J; Garcia-Garcia, L; Gallego-Alberto, L; Cabrera, I.

Longitudinal support to the sociocultural stress and coping model. A 4-year follow-up of family caregivers of people with dementia

INTERNATIONAL PSYCHOGERIATRICS. 2025; 37(4): Nº de citas: 1 [doi:10.1016/j.inpsyc.2025.100079]

Gomez-Llobell, M; Smith, CS; Gómez-Costas, D; Gómez-Centurión, I; Domínguez, JMG; Escudero-Vilaplana, V; Bullido, YF; Carbonell, D; Pion, M; Bailén, R; Gil-Perotin, S; Ginés, MLM; Revuelta-Herrero, JL; Fernández-Caldas, P; Fernández, VAP; Collado-Borrell, R; Bastos-Oreiro, M; Villanueva-Bueno, C; García-Sanz, R; Kwon, M.

ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling

BONE MARROW TRANSPLANTATION. 2025; : Nº de citas: 7 [doi:10.1038/s41409-025-02679-y]